• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TOSOH BIOSCIENCE, INC. AIA 2000

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TOSOH BIOSCIENCE, INC. AIA 2000 Back to Search Results
Model Number AIA 2000
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 05/20/2020
Event Type  malfunction  
Manufacturer Narrative
Device evaluation by manufacturer: a 13-month complaint history review and service history review through aware date of event for similar complaints was performed for serial number (b)(4).There were no other similar complaints found during the searched period.A 13-month lot review for bhcg calibrator lot jx33532 was performed through aware date of event.There were no other similar complaints found during the searched period.The st aia-pack beta human chorionic gonadotropin (bchg) analyte application manual states the following: evaluation of results: quality control.In order to monitor and evaluate the precision of the analytical performance, it is recommended that commercially available control samples be assayed daily.The minimum recommendations for the frequency of running internal control material are: after calibration, two levels of controls are run in order to accept the calibration curve.The two levels of controls are also repeated after calibration when certain service procedures are performed (e.G.Temperature adjustment, sampling mechanism changes, maintenance of the wash probe or detector lamp adjustment or change).After daily maintenance, at least two levels of the control should be run in order to verify the overall performance of the tosoh aia system analyzers.If one or more control sample value(s) is out of the acceptable range, it will be necessary to investigate the validity of the calibration curve before reporting patient results.Standard laboratory procedures should be followed in accordance with the regulatory agency under which the laboratory operates.Limitations of the procedure: for diagnostic purposes, the results obtained from this assay should be used in conjunction with other data (e.G., symptoms, results of other tests, clinical impressions, therapy, etc.).Using st aia-pack bhcg, the highest concentration of total beta hcg measurable without dilution is 400 miu/ml, and the lowest measurable concentration is 0.5 miu/ml (assay sensitivity).Although the approximate value of the highest calibrator is 200 miu/ml, the exact concentration may be slightly different.The assay specification, assay range high, should be defined as the upper limit of the assay range, 400 miu/ml.Although hemolysis has an insignificant effect on the assay, hemolyzed samples may indicate mistreatment of a specimen prior to assay and results should be interpreted with caution.The most probable cause of the reported event was due to normal lot to lot variability.
 
Event Description
A customer reported out of range quality control results for beta human chorionic gonadotropin (bhcg) after calibration with new calibrator lot jx33532 on the aia-2000 instrument.Technical support specialist (tss) sent new calibrator lot to the customer.The customer recalibrated and completed quality control without errors and results are now in range.No further action required by tss.The aia-2000 instrument is functioning as expected.There was no indication of patient intervention or adverse health consequences due to delay in reporting beta human chorionic gonadotropin patient samples.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AIA 2000
Type of Device
AIA 2000
Manufacturer (Section D)
TOSOH BIOSCIENCE, INC.
3600 gantz road
grove city, oh
Manufacturer (Section G)
TOSOH BIOSCIENCE, INC.
3600 gantz road
grove city, oh
Manufacturer Contact
bernadette oconnell
6000 shoreline court
suite 101
south san francisco, ca 
9368143
MDR Report Key10174909
MDR Text Key202409765
Report Number3005529799-2020-00041
Device Sequence Number1
Product Code KHO
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K971103
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 06/19/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberAIA 2000
Device Catalogue Number022100
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 05/20/2020
Initial Date FDA Received06/19/2020
Was Device Evaluated by Manufacturer? No
Date Device Manufactured02/05/2015
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
-
-